
John M. Cooney
Examiner (ID: 1913, Phone: (571)272-1070 , Office: P/1765 )
| Most Active Art Unit | 1765 |
| Art Unit(s) | 1641, 1711, 1503, 1207, 1796, 1765 |
| Total Applications | 2625 |
| Issued Applications | 1714 |
| Pending Applications | 193 |
| Abandoned Applications | 736 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18978873
[patent_doc_number] => 11904027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 16/827606
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14064
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827606
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/827606 | Stable, concentrated radionuclide complex solutions | Mar 22, 2020 | Issued |
Array
(
[id] => 16189414
[patent_doc_number] => 20200230263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => NOVEL DEUTERIUM SUBSTITUTED POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS AND THEIR PHARMACOLOGICAL APPLICATION
[patent_app_type] => utility
[patent_app_number] => 16/824139
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16824139
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/824139 | Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application | Mar 18, 2020 | Issued |
Array
(
[id] => 16862721
[patent_doc_number] => 11021450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => PSMA targeted fluorescent agents for image guided surgery
[patent_app_type] => utility
[patent_app_number] => 16/820052
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 50
[patent_no_of_words] => 23394
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16820052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/820052 | PSMA targeted fluorescent agents for image guided surgery | Mar 15, 2020 | Issued |
Array
(
[id] => 19490591
[patent_doc_number] => 12109276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Near-infrared dyes and conjugates for targeting tumors
[patent_app_type] => utility
[patent_app_number] => 16/816118
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 5631
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16816118
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/816118 | Near-infrared dyes and conjugates for targeting tumors | Mar 10, 2020 | Issued |
Array
(
[id] => 16052957
[patent_doc_number] => 20200188333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => ABUSE-PROOFED DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 16/797016
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797016
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/797016 | ABUSE-PROOFED DOSAGE FORM | Feb 20, 2020 | Abandoned |
Array
(
[id] => 16153641
[patent_doc_number] => 20200215053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => ABUSE-PROOFED DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 16/797055
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797055
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/797055 | ABUSE-PROOFED DOSAGE FORM | Feb 20, 2020 | Abandoned |
Array
(
[id] => 15928165
[patent_doc_number] => 20200155716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => RADIOACTIVE COMPOSITIONS AND METHODS FOR THEIR THERAPEUTIC USE
[patent_app_type] => utility
[patent_app_number] => 16/773398
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773398
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773398 | Radioactive compositions and methods for their therapeutic use | Jan 26, 2020 | Issued |
Array
(
[id] => 16009343
[patent_doc_number] => 20200179514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => PHTHALOCYANINE PROBES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/751850
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751850
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751850 | PHTHALOCYANINE PROBES AND USES THEREOF | Jan 23, 2020 | Abandoned |
Array
(
[id] => 17505116
[patent_doc_number] => 20220098218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPLEX OF GADOLINIUM AND A CHELATING LIGAND DERIVED OF A DIASTEREOISOMERICALLY ENRICHED PCTA AND SYNTHESIS METHOD
[patent_app_type] => utility
[patent_app_number] => 17/423589
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423589
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423589 | COMPLEX OF GADOLINIUM AND A CHELATING LIGAND DERIVED OF A DIASTEREOISOMERICALLY ENRICHED PCTA AND SYNTHESIS METHOD | Jan 16, 2020 | Abandoned |
Array
(
[id] => 17306349
[patent_doc_number] => 11207432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Substituted organofluoroborates as imaging agents
[patent_app_type] => utility
[patent_app_number] => 16/746458
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 45
[patent_no_of_words] => 33668
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1648
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16746458
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/746458 | Substituted organofluoroborates as imaging agents | Jan 16, 2020 | Issued |
Array
(
[id] => 15996277
[patent_doc_number] => 20200174009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => CA IX - NIR DYES AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 16/723319
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723319
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/723319 | CA IX--NIR dyes and their uses | Dec 19, 2019 | Issued |
Array
(
[id] => 15990609
[patent_doc_number] => 20200171175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => MULTIPURPOSE MEDICAL IMAGE INDICATOR AND METHOD FOR MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/721215
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721215
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721215 | Multipurpose medical image indicator and method for manufacturing the same | Dec 18, 2019 | Issued |
Array
(
[id] => 17291030
[patent_doc_number] => 20210386869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => DELIVERY OF CYCLIC COMPOUND BY USING CARRIER
[patent_app_type] => utility
[patent_app_number] => 17/299960
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299960
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299960 | DELIVERY OF CYCLIC COMPOUND BY USING CARRIER | Dec 5, 2019 | Pending |
Array
(
[id] => 15740473
[patent_doc_number] => 20200109124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY
[patent_app_type] => utility
[patent_app_number] => 16/704137
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16704137
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/704137 | PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY | Dec 4, 2019 | Abandoned |
Array
(
[id] => 16589352
[patent_doc_number] => 10898595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Core-satellite nanocomposites for MRI and photothermal therapy
[patent_app_type] => utility
[patent_app_number] => 16/694715
[patent_app_country] => US
[patent_app_date] => 2019-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 11276
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16694715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/694715 | Core-satellite nanocomposites for MRI and photothermal therapy | Nov 24, 2019 | Issued |
Array
(
[id] => 17921657
[patent_doc_number] => 11464878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Biospecific agents for bone
[patent_app_type] => utility
[patent_app_number] => 16/693780
[patent_app_country] => US
[patent_app_date] => 2019-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 10743
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693780
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/693780 | Biospecific agents for bone | Nov 24, 2019 | Issued |
Array
(
[id] => 16842868
[patent_doc_number] => 11014942
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Preparation of a solid form of gadobenate dimeglumine
[patent_app_type] => utility
[patent_app_number] => 16/678082
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8027
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16678082
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/678082 | Preparation of a solid form of gadobenate dimeglumine | Nov 7, 2019 | Issued |
Array
(
[id] => 15895397
[patent_doc_number] => 20200147217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => FUCOIDAN-BASED THERAGNOSTIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/677104
[patent_app_country] => US
[patent_app_date] => 2019-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16677104
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/677104 | FUCOIDAN-BASED THERAGNOSTIC COMPOSITION | Nov 6, 2019 | Abandoned |
Array
(
[id] => 16108699
[patent_doc_number] => 20200206372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => DEVICES AND METHODS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/598285
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16598285
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/598285 | DEVICES AND METHODS FOR THE TREATMENT OF CANCER | Oct 9, 2019 | Abandoned |
Array
(
[id] => 15432557
[patent_doc_number] => 20200030461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => Compositions of Near IR Closed Chain, Sulfo-Cyanine Dyes and Prostate Specific Membrane Antigen Ligands
[patent_app_type] => utility
[patent_app_number] => 16/593207
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16593207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/593207 | Compositions of near IR closed chain, sulfo-cyanine dyes and prostate specific membrane antigen ligands | Oct 3, 2019 | Issued |